Javier Colás Fustero

Exploring tear-derived extracellular vesicles as diagnostic biomarkers for ocular and neurodegenerative diseases: in this review article, Marta San Roque, Francesc E. Borràs at Germans Trias i Pujol Research Institute (IGTP) and collaborators discussed the potential of tear-derived extracellular vesicles as biomarkers for the early detection and monitoring of ocular and neurodegenerative diseases and emphasized the need to standardize tear collection and EV isolation protocols to improve reproducibility. Emerging evidence showed that tear-derived EVs offer a minimally invasive and accessible source for early diagnosis, as tears reflect the physiological state of the eye and can reveal inflammatory or pathological changes 🔗 https://lnkd.in/eZiYC34x Studies demonstrated that tear-derived EVs carry molecular signatures, including proteins and various RNA species, representative of their cells of origin, enabling the identification of biomarkers for both ocular and neurodegenerative conditions. The authors noted that consistent methodological standards and transparent reporting are essential to validate and advance the clinical utility of tear-derived EVs. An article co-authored by Sergio Garcia Garcia, linrong pan, Marta Clos Sansalvador, Miriam Font Morón, Jessica Botella Garcia, MD, FEBO, Jordi Loscos Arenas. #extracellularvesicles #exosomes #biomarkers #neurodegeneration #Vesiculab

164

4 comentarios

We're thrilled to share that a new funding boost will allow our #Endometriosis researchers to expand an exciting international #Collaboration! 🌍 🧬 Led by Prof Caroline Gargett, our team, together with colleagues from Monash University is partnering with Universitat de Barcelona, Hospital Universitari i Politècnic La Fe de València, and the Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré - IRBLLEIDA, is using multicellular organoids to research how endo lesions develop, like never before. 🇪🇸 🇦🇺 This Spanish-Australian research collaboration will strengthen our work to better understand and treat endometriosis, improving outcomes for sufferers worldwide. Read more: https://bit.ly/4owd3sF

82

5 comentarios

Today, the World Heart Federation’s Chief Operating Officer Borjana Pervan opened the RISE @ ESC Congress in Madrid with a powerful call to action: “I want women to have access to the rooms, to the tables, to the hospitals, innovation and research centers that they need to enter to be able to improve heart care. As the mother of three daughters, I know they deserve to be led and taught by people who look like them." Over the past years, we’ve built platforms that give women tools, knowledge and space. Through our Emerging Leaders Programme, we’ve supported over 240 professionals from more than 60 countries, with nearly half being women. Borjana highlighted personal stories of women who joined the programme, and how it gave them the chance to develop their own leadership models. Thank you to Mariachiara Di Cesare, Zainab Dakhil, and Lilian Mbau, MD, MPH, MSc (Prev. Cardio), CRFC for sharing their stories with us. Borjana closed with a reflection that reaffirms WHF’s position: “Our mission is clear: to reach everyone, everywhere with cardiovascular health. That means removing every barrier that stands in the way. And it means creating space for women to rise, lead, and transform cardiology on their terms." Thank you to Women As One and European Society of Cardiology for co-hosting this important event with us. Learn more about RISE here: https://lnkd.in/dtgJN-KS #ESCCongress #WCCardio #LetsRise2025

147

2 comentarios

Jaume Capdevila, MD, PhD, presents results from a phase 1 study showing that obrixtamig monotherapy achieves a 40% response rate and durable disease control with manageable safety in patients with extrapulmonary neuroendocrine carcinoma. Watch the full video here: https://lnkd.in/gmF2bvZc

68

Missed our live session at Society of European Robotic Gynaecological Surgery (SERGS) 2025 in Pisa? You can now watch the full recording of the SERGS symposium! 👉 https://lnkd.in/dDCmuqnM What does robotic integration into daily gynecology practice look like with the DEXTER Robotic Surgery System? Prof. Martin Heubner (Kantonsspital Baden AG) shared key takeaways from his first DEXTER cases and how an instinctive system supports fast adoption. Dr. Marietta Gulz (Insel Gruppe, Inselspital Bern) presented insights from over 98 DEXTER procedures – including outcomes, workflow integration, and data from two multicenter studies. Clinical experience includes: • (Bikini-line) hysterectomy • Large uterus myomatosus • Deep infiltrating endometriosis • Complex myomectomy with extensive suturing We will continue to advance access to robotic surgery — wherever care is delivered. #DEXTER #RoboticSurgery #Gynecology #Distalmotion #EmpoweringAccess

94

📄 Out now – the ERS & EULAR - European Alliance of Associations for Rheumatology clinical practice guideline on connective tissue diseases with ILD involvement has now been published in the European Respiratory Journal. Access the new guideline online: https://lnkd.in/epV8XHrX

202

1 comentario